Listed

Humana Inc: Form 10-Q for the period ended Mar 31, 2013

Filed with the SEC on May 1, 2013 and accepted by EDGAR at May 1, 2013, 16:02 ET.

Share

Management's discussion and analysis

As filed, 67,495 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The condensed consolidated financial statements of Humana Inc. in this document present the Company’s financial position, results of operations and cash flows, and should be read in conjunction with the following discussion and analysis. References to “we,” “us,” “our,” “Company,” and “Humana” mean Humana Inc. and its subsidiaries. This discussion includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in filings with the SEC, in our press releases, investor presentations, and in oral statements made by or with the approval of one of our executive officers, the words or phrases like “expects,” “believes,” “anticipates,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such forward–looking statements. These forward–looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, including, among other things, information set forth in Item 1A. – Risk Factors in our 2012 Form 10-K, as modified by any changes to those risk factors included in this document and in other reports we filed subsequent to February 21, 2013, in each case incorporated by reference herein. In making these statements, we are not undertaking to address or update such forward-looking statements in future filings or communications regarding our business or results. In light of these risks, uncertainties and assumptions, the forward–looking events discussed in this document might not occur. There may also be other risks that we are unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward–looking statements.

Executive Overview

General

Headquartered in Louisville, Kentucky, Humana is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of our core businesses, we believe that we can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom we have relationships.

Our industry relies on two key statistics to measure performance. The benefit ratio, which is computed by taking total benefits expense as a percentage of premiums revenue, represents a statistic used to measure underwriting profitability. The operating cost ratio, which is computed by taking total operating costs as a percentage of total revenue less investment income, represents a statistic used to measure administrative spending efficiency.

Business Segments

On January 1, 2013, we reclassified certain of our businesses to correspond with internal management reporting changes and renamed our Health and Well-Being Services segment as Healthcare Services as further described in Note 1 to the condensed consolidated financial statements. Prior period segment financial information has been recast to conform to the 2013 presentation.

We manage our business with three reportable segments: Retail, Employer Group, and Healthcare Services. In addition, the Other Businesses category includes businesses that are not individually reportable because they do not meet the quantitative thresholds required by generally accepted accounting principles. These segments are based on a combination of the type of health plan customer and adjacent businesses centered on integrated care delivery for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer to assess performance and allocate resources.

The Retail segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products, marketed directly to individuals, and includes our contract with Centers for Medicare and Medicaid Services, or CMS, to administer the Limited Income Newly Eligible Transition program, or the LI-NET program and state-based Medicaid businesses. The Employer Group segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products, as well as administrative services only products and our health and productivity solutions products primarily marketed to employer groups. The Healthcare Services segment includes services offered to our health plan members as well as to third parties, including provider services, pharmacy, integrated behavioral health services, and home care services. The Other Businesses category consists of our military services, primarily our TRICARE South Region contract, Puerto Rico Medicaid, and closed-block long-term care businesses.

The results of each segment are measured by income before income taxes. Transactions between reportable segments consist of sales of services rendered by our Healthcare Services segment, primarily pharmacy, provider, and behavioral health, to our Retail and Employer Group customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often utilize the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at the corporate level. These corporate amounts are reported separately from our reportable segments and included with intersegment eliminations.

Seasonality

One of the product offerings of our Retail segment is Medicare stand-alone prescription drug plans, or PDPs, under the Medicare Part D program. These plans provide varying degrees of coverage. Our quarterly Retail segment earnings and operating cash flows are impacted by the Medicare Part D benefit design and changes in the composition of our membership. The Medicare Part D benefit design results in coverage that varies as a member’s cumulative out-of-pocket costs pass through successive stages of a member’s plan period which begins annually on January 1 for renewals. These plan designs generally result in us sharing a greater portion of the responsibility for total prescription drug costs in the early stages and less in the latter stages. As a result, the PDP benefit ratio generally decreases as the year progresses. In addition, the number of low-income senior members as well as year-over-year changes in the mix of membership in our stand-alone PDP products affects the quarterly benefit ratio pattern.

Our Employer Group segment also experiences seasonality in the benefit ratio pattern. However, the effect is opposite of the Retail segment, with the Employer Group’s benefit ratio increasing as fully-insured members progress through their annual deductible and maximum out-of-pocket expenses.

2013 Highlights

Consolidated

  • Our results for the three months ended March 31, 2013 were impacted by a lower benefit ratio in most of our major business lines and a lower operating cost ratio in our Retail and Employer Group segments due to continued operating cost efficiencies. The decline in the benefit ratio primarily was due to higher favorable prior-period medical claims reserve development year-over-year mainly resulting from a lower claims trend across most of our major business lines, and favorable weekday seasonality (the number of business days in the period), including the impact of an extra day’s claims for leap year in 2012. In addition, the benefit ratio for the three months ended March 31, 2013 includes the beneficial effect of a favorable settlement of contract claims with the Department of Defense, or DoD, primarily associated with previously disclosed litigation settled in the second quarter of 2012. As more fully described under “Benefits Expense Recognition” in Item 7 of our 2012 Form 10-K, actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. We experienced favorable medical claims reserve development related to prior fiscal years of $266 million for the three months ended March 31, 2013 compared to $141 million for the three months ended March 31, 2012.
  • In addition, our 2013 results reflect the continued implementation of our strategy to offer our members affordable health care combined with a positive consumer experience in growing markets. At the core of this strategy is our integrated care delivery model, which unites quality care, high member engagement, and sophisticated data analytics. Our approach to primary, physician-directed care for our members aims to provide quality care that is consistent, integrated, cost-effective, and member-focused. The model is

designed to improve health outcomes and affordability for individuals and for the health system as a whole, while offering our members a simple, seamless healthcare experience. We believe this strategy is positioning us for long-term growth in both membership and earnings. At March 31, 2013, approximately 530,300 members, or 26.4%, of our individual Medicare Advantage membership were in risk arrangements under our integrated care delivery model, as compared to 511,700 members at December 31, 2012 and 497,900 members at March 31, 2012.

  • Comparisons to our 2012 consolidated benefit ratio and operating cost ratio are impacted by the transition to the new TRICARE South Region contract on April 1, 2012, which is accounted for similar to an administrative services fee only agreement as described in Note 2 to the consolidated financial statements included in our 2012 Form 10-K. Our previous contract was accounted for similar to our fully-insured products.
  • During the three months ended March 31, 2013, we repurchased 1.21 million shares in open market transactions for $81 million and declared dividends to stockholders of $0.26 per share for an aggregate amount of $41 million.

Retail

  • On April 1, 2013, CMS issued its final Announcement of Calendar Year 2014 Medicare Advantage Benchmark Rates and Payment Policies, which we refer to as the CMS Final Announcement. Based on the benchmark rates and payment policies published in the CMS Final Announcement, we estimate that our 2014 Medicare bid benchmark payment rates will decline by 2.8% in the aggregate, including the negative impact of risk coding recalibration and county rebasing. The 2014 bid benchmark payment rate reductions for certain of our key markets are anticipated to be in the mid to upper single digits, primarily due to the risk coding recalibration in 2014. Including the health insurance industry fee associated with Health Insurance Reform Law, we anticipate we will need to address government funding reductions of more than 4% in the aggregate in 2014. While we believe our senior members’ benefits may be adversely impacted, we believe we can effectively design Medicare Advantage products based upon these levels of rate reduction while continuing to remain competitive compared to both the combination of original Medicare with a supplement policy as well as Medicare Advantage products offered by our competitors. Nonetheless, there can be no assurance that we will be able to successfully execute operational and strategic initiatives that we have assumed when designing our plan benefit offerings and premiums for 2014. Failure to execute these strategies may result in a material adverse effect on our results of operations, financial position, and cash flows.
  • As discussed in the detailed Retail segment results of operations discussion that follows, we experienced a decline in the benefit ratio in the Retail segment, with the segment’s benefit ratio decreasing 160 basis points to 85.9% for the three months ended March 31, 2013 primarily due to the factors described above under our consolidated highlights.
  • Individual Medicare Advantage membership of 2,012,100 at March 31, 2013 increased 84,500, or 4.4%, from 1,927,600 at December 31, 2012 and increased 128,300 members, or 6.8%, from 1,883,800 at March 31, 2012 reflecting net membership additions for the 2013 enrollment season. Effective January 1, 2013, we divested approximately 12,600 members acquired with Arcadian Management Services, Inc. in accordance with our previously disclosed agreement with the United States Department of Justice.
  • Medicare stand-alone PDP membership of 3,202,300 at March 31, 2013 increased 149,600 members, or 4.9%, from 3,052,700 at December 31, 2012 and increased 261,700 members, or 8.9%, from 2,940,600 at March 31, 2012 reflecting net membership additions, primarily for our Humana-Walmart plan offering for the 2013 enrollment season.
  • During 2012, we were successful in our bids for Medicaid business in Ohio, Illinois, and Kentucky, including individuals dually eligible for both the federal Medicare program and the state-based Medicaid program in both Ohio and Illinois. We partnered with CareSource Management Group Company to serve the Ohio and Kentucky individuals under a March 2012 strategic alliance agreement. Medicaid membership in our Retail Segment increased 21,200 members from December 31, 2012, and increased 27,200 members from March 31, 2012 primarily driven by the addition of our recently awarded Kentucky Medicaid contract effective January 1, 2013. We expect to begin serving members under contracts with Ohio and Illinois on January 1, 2014.

Employer Group Segment

  • As discussed in the detailed Employer Group segment results of operations discussion that follows, we experienced a decline in the benefit ratio in the Employer Group segment, with the segment’s benefit ratio decreasing 160 basis points to 79.6% for the three months ended March 31, 2013 primarily due to the factors described above under our consolidated highlights.
  • Fully-insured group Medicare Advantage membership of 412,800 at March 31, 2013 increased 42,000 members, or 11.3%, from 370,800 at December 31, 2012 and increased 55,100 members, or 15.4%, from 357,700 at March 31, 2012 primarily due to the January 2013 addition of a new large group retirement account.

Other Businesses

  • Year-over-year comparisons within Other Businesses are impacted by the transition to the new TRICARE South Region contract on April 1, 2012, including a change in profitability under the new contract in connection with our bid strategy, and a reduction in benefits expense of approximately $48 million during the three months ended March 31, 2013 related to a favorable settlement of contract claims with the DoD primarily associated with previously disclosed litigation settled in the second quarter of 2012.

Health Insurance Reform

The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Insurance Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. While regulations and interpretive guidance on some provisions of the Health Insurance Reform Law have been issued to date by the Department of Health and Human Services, or HHS, the Department of Labor, the Treasury Department, and the National Association of Insurance Commissioners, or NAIC, there are many provisions of the legislation that will require additional guidance and clarification in the form of regulations and interpretations in order to fully understand the impacts of the legislation on our overall business, which we expect to occur over the next several years.

Implementation dates of the Health Insurance Reform Law began in September 2010 and continue through 2018. The following outlines certain provisions of the Health Insurance Reform Law:

  • Currently Effective: Many changes are already effective and have been implemented by the Company, including: elimination of pre-existing condition limits for enrollees under age 19, elimination of certain annual and lifetime caps on the dollar value of benefits, expansion of dependent coverage to include adult children until age 26, a requirement to provide coverage for prescribed preventive services without cost to members, new claim appeal requirements, and the establishment of an interim high risk program for those unable to obtain coverage due to a pre-existing condition or health status.

Commercial fully-insured medical plans with actual benefit ratios below certain targets (85% for large employer groups, 80% for small employer groups, and 80% for individuals, calculated in a manner prescribed by HHS) are required to rebate ratable portions of their premiums to customers annually. We began accruing for rebates in 2011, based on the manner prescribed by HHS, with initial rebate payments made in July 2012. Our benefit ratios reported herein, calculated from financial statements prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, differ from the benefit ratios calculated as prescribed by HHS under the Health Insurance Reform Law. The more noteworthy differences include the fact that the benefit ratio calculations prescribed by HHS are calculated separately by state and legal entity; independently for individual, small group, and large group fully-insured products; reflect actuarial adjustments where the membership levels are not large enough to create credible size; exclude some of our health insurance products; include taxes and fees as reductions of premium; and treat changes in reserves differently than GAAP.

HHS has also established, as required under the Health Insurance Reform Law, a federal premium rate review process, which generally applies to proposed rate increases equal to or exceeding 10%, and regulations require commercial plans to provide to the states and HHS supporting information with respect to any rate increases that are subject to the federal review process.

  • Currently Effective with Phased-In Implementation: In 2012, additional cuts to Medicare Advantage plan payment benchmarks began to take effect (with plan payment benchmarks ultimately ranging from 95% in high-cost

areas to 115% in low-cost areas of Medicare fee-for-service rates), with changes being phased-in over two to six years, depending on the level of payment reduction in a county. In addition, since 2011 the gap in coverage for Medicare Part D prescription drug coverage has been incrementally closing.

In addition, certain provisions in the Health Insurance Reform Law tie Medicare Advantage premiums to the achievement of certain quality performance measures (Star Ratings). Beginning in 2012, Medicare Advantage plans with an overall Star Rating of three or more stars (out of five) were eligible for a quality bonus in their basic premium rates. Initially, quality bonuses were limited to the few plans that achieved four or more stars as an overall rating, but CMS has expanded the quality bonus to three Star plans for a three year period through 2014. Star Ratings issued by CMS in October 2012 indicated that 99% of our Medicare Advantage members are now in plans that will qualify for quality bonus payments in 2014, up from 98% in 2013. Further, the percentage of our Medicare Advantage members in plans with an overall Star Rating of four or more stars, including one five star plan, increased to 40%. Plans that earn an overall Star Rating of five are immediately eligible to enroll members year round. Beginning in 2015, plans must have a Star Rating of four or higher to qualify for bonus money. Notwithstanding successful historical efforts to improve our Star Ratings and other quality measures for 2012 and 2013 and the continuation of such efforts, there can be no assurances that we will be successful in maintaining or improving our Star Ratings in future years. Accordingly, our plans may not be eligible for full level quality bonuses, which could adversely affect the benefits such plans can offer, reduce membership, and/or reduce profit margins.

  • Effective in 2014: Beginning in 2014, the Health Insurance Reform Law requires: all individual and group health plans to guarantee issuance and renew coverage without pre-existing condition exclusions or health-status rating adjustments; the elimination of annual limits on coverage on certain plans; the establishment of federally facilitated or state-based exchanges for individuals and small employers (with up to 100 employees) coupled with programs designed to spread risk among insurers; the introduction of plan designs based on set actuarial values; the establishment of a minimum benefit ratio of 85% for Medicare plans; and insurance industry assessments, including an annual health insurance industry fee and a three-year $25 billion commercial reinsurance fee. The annual health insurance industry fee levied on the insurance industry is $8 billion in 2014 with increasing annual amounts thereafter, growing to $14 billion by 2017, and is not deductible for income tax purposes, which will significantly increase our effective income tax rate in 2014. The NAIC is continuing discussions regarding the accounting for the health insurance industry fee and may require accrual and associated subsidiary funding consideration for the first two years of the assessment in 2014 followed by annual accruals thereafter. The NAIC guidance is contradictory to final GAAP guidance issued by the FASB in July 2011, which requires annual accrual of the health insurance industry fee in the year in which it is payable.

The Health Insurance Reform Law also specifies benefit design guidelines, limits rating and pricing practices, encourages additional competition (including potential incentives for new market entrants), and expands eligibility for Medicaid programs. In addition, the law will increase federal oversight of health plan premium rates and could adversely affect our ability to appropriately adjust health plan premiums on a timely basis. Financing for these reforms will come, in part, from material additional fees and taxes on us and other health plans and individuals beginning in 2014, as well as reductions in certain levels of payments to us and other health plans under Medicare as described herein.

As discussed above, implementing regulations and related interpretive guidance continue to be issued on several significant provisions of the Health Insurance Reform Law. Congress may also withhold the funding necessary to implement the Health Insurance Reform Law, or may attempt to replace the legislation with amended provisions. Given the breadth of possible changes and the uncertainties of interpretation, implementation, and timing of these changes, which we expect to occur over the next several years, the Health Insurance Reform Law will change the way we do business, potentially impacting our pricing, benefit design, product mix, geographic mix, and distribution channels. In particular, final implementing regulations and related guidance are forthcoming on various aspects of the minimum benefit ratio requirement’s applicability to Medicare, including aggregation, credibility thresholds, and its application to prescription drug plans. The response of other companies to the Health Insurance Reform Law and adjustments to their offerings, if any, could cause meaningful disruption in the local health care markets. It is reasonably possible that the Health Insurance Reform Law and related regulations, as well as future legislative changes, in the aggregate may have a material adverse effect on our results of operations, including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs, lowering our Medicare payment rates and increasing our expenses associated with the non-deductible health insurance industry fee and other assessments; our financial position, including our ability to maintain the value of our goodwill; and our cash flows. If the new non-deductible health insurance industry fee and other assessments, including a three-year commercial reinsurance fee, were imposed as enacted, and if we are unable to adjust our business model to address these new taxes and assessments, such as through the reduction of our operating costs or adjustments to premium pricing or benefit design, there can be no assurance that the non-deductible health insurance industry fee and other assessments would not have a material adverse effect on our results of operations, financial position, and cash flows.

We intend for the discussion of our financial condition and results of operations that follows to assist in the understanding of our financial statements and related changes in certain key items in those financial statements from year to year, including the primary factors that accounted for those changes. Transactions between reportable segments consist of sales of services rendered by our Healthcare Services segment, primarily pharmacy, provider, and behavioral health services, to our Retail and Employer Group customers and are described in Note 12 to the condensed consolidated financial statements.

Comparison of Results of Operations for 2013 and 2012

The following discussion primarily deals with our results of operations for the three months ended March 31, 2013, or the 2013 quarter, and the three months ended March 31, 2012, or the 2012 quarter.

Consolidated

(dollars in millions, except per common share results)

Revenues: Premiums: For the three months ended March 31, 2013 2012 Change Dollars Percentage
Retail $6,904 $6,147 $757 12.3%
Employer Group 2,735 2,529 206 8.1%
Other Businesses 229 1,099 (870) (79.2)%
Total premiums 9,868 9,775 93 1.0%
Services:
Retail 2 6 (4) (66.7)%
Employer Group 88 91 (3) (3.3)%
Healthcare Services 315 235 80 34.0%
Other Businesses 120 18 102 566.7%
Total services 525 350 175 50.0%
Investment income 93 94 (1) (1.1)%
Total revenues 10,486 10,219 267 2.6%
Operating expenses:
Benefits 8,195 8,350 (155) (1.9)%
Operating costs 1,446 1,383 63 4.6%
Depreciation and amortization 80 70 10 14.3%
Total operating expenses 9,721 9,803 (82) (0.8)%
Income from operations 765 416 349 83.9%
Interest expense 35 26 9 34.6%
Income before income taxes 730 390 340 87.2%
Provision for income taxes 257 142 115 81.0%
Net income $473 $248 $225 90.7%
Diluted earnings per common share $2.95 $1.49 $1.46 98.0%
Benefit ratio(a) 83.0% 85.4% (2.4)%
Operating cost ratio(b) 13.9% 13.7% 0.2%
Effective tax rate 35.2% 36.5% (1.3)%

(a) Represents total benefits expense as a percentage of premiums revenue.

(b) Represents total operating costs as a percentage of total revenues less investment income.

Summary

Net income was $473 million, or $2.95 per diluted common share, in the 2013 quarter compared to $248 million, or $1.49 per diluted common share, in the 2012 quarter primarily due to declines in both the benefit ratio and operating cost ratio in both the Retail and Employer Group segments. The declines in the benefit ratio primarily reflect higher favorable prior-period medical claims reserve development year-over-year mainly resulting from a lower claims trend across most of our major business lines, and favorable weekday seasonality, including the impact of an extra day’s claims for leap year in 2012. The lower operating cost ratios in our Retail and Employer Group segments reflect continued administrative cost efficiencies. Our diluted earnings per common share for the 2013 quarter included the benefit of $0.19 per diluted common share for a reduction in benefits expense related to a favorable settlement of contract claims with the DoD primarily associated with previously disclosed litigation settled in the second quarter of 2012.

Premiums

Consolidated premiums increased $93 million, or 1.0%, from the 2012 quarter to $9.9 billion for the 2013 quarter primarily due to increases in both Retail and Employer Group segment premiums mainly driven by higher average individual and group Medicare Advantage membership, partially offset by lower premiums for our Other Businesses due to the transition to the new TRICARE South Region contract. As discussed in Note 2 to the consolidated financial statements included in our 2012 Form 10-K, on April 1, 2012, we began delivering services under the new TRICARE South Region contract that the TMA awarded to us on February 25, 2011. We account for revenues under the new contract net of estimated healthcare costs similar to an administrative services fee only agreement, and as such there are no premiums recognized under the new contract. Our previous contract was accounted for similar to our fully-insured products and as such we recognized premiums under the previous contract. Average membership is calculated by summing the ending membership for each month in a period and dividing the result by the number of months in a period. Premiums revenue reflects changes in membership and average per member premiums. Items impacting average per member premiums include changes in premium rates as well as changes in the geographic mix of membership, the mix of product offerings, and the mix of benefit plans selected by our membership.

Services revenue

Consolidated services revenue increased $175 million, or 50.0%, from the 2012 quarter to $525 million for the 2013 quarter primarily due to an increase in services revenue for our Other Businesses due to the transition to the new TRICARE South Region contract on April 1, 2012, and an increase in services revenue in our Healthcare Services segment. The increases in services revenue in our Healthcare Services segment primarily resulted from the acquisition of Metropolitan Health Networks, Inc., or Metropolitan, on December 21, 2012 and SeniorBridge Family Companies, Inc., or SeniorBridge, on July 6, 2012, and growth in our Concentra operations.

Investment income

Investment income totaled $93 million for the 2013 quarter compared to $94 million for the 2012 quarter as higher average invested balances were more than offset by lower interest rates.

Benefits expense

Consolidated benefits expense was $8.2 billion for the 2013 quarter, a decrease of $155 million, or 1.9%, from the 2012 quarter primarily due to a decrease in benefits expense for Other Businesses primarily due to the transition to the new administrative services only TRICARE South Region contract on April 1, 2012, partially offset by a year-over-year increase in Retail segment benefits expense, primarily driven by an increase in the average number of Medicare members. We do not record benefits expense under the new TRICARE South Region contract. Our previous contract was accounted for similar to our fully-insured products and as such we recorded benefits expense under the previous contract. Retail segment benefits expense increased $552 million, or 10.3%, from the 2012 quarter to the 2013 quarter primarily due to membership growth. We experienced favorable medical claims reserve development related to prior fiscal years of $266 million in the 2013 quarter and $141 million in the 2012 quarter, primarily resulting from a lower claims trend across most of our major business lines.

The consolidated benefit ratio for the 2013 quarter was 83.0%, a 240 basis point decrease from the 2012 quarter primarily due to decreases in both the Retail and Employer Group segments benefit ratios as described further in our segment results discussion that follows, as well as the beneficial effect in the 2013 quarter of a favorable settlement of contract claims with the DoD primarily associated with previously disclosed litigation settled in the second quarter of 2012. The $125 million increase in favorable prior-period medical claims reserve development from the 2012 quarter to the 2013 quarter positively impacted year-over-year comparisons of the benefit ratio.

Operating costs

Our segments incur both direct and shared indirect operating costs. We allocate the indirect costs shared by the segments primarily as a function of revenues. As a result, the profitability of each segment is interdependent.

Consolidated operating costs increased $63 million, or 4.6%, during the 2013 quarter compared to the 2012 quarter primarily due to an increase in operating costs in our Healthcare Services segment as a result the acquisition of Metropolitan on December 21, 2012 and SeniorBridge on July 6, 2012.

The consolidated operating cost ratio for the 2013 quarter was 13.9%, increasing 20 basis points from the 2012 quarter as the negative impact of the new TRICARE South Region contract being accounted for as an administrative services fee only arrangement was partially offset by improved operating leverage in our Retail and Employer Group segments.

Depreciation and amortization

Depreciation and amortization for the 2013 quarter totaled $80 million, an increase of $10 million, or 14.3%, from the 2012 quarter primarily due to increased amortization expense in the 2013 quarter from the acquisition of Metropolitan in the fourth quarter of 2012.

Interest expense

Interest expense was $35 million for the 2013 quarter compared to $26 million for the 2012 quarter, an increase of $9 million, or 34.6%. In December 2012, we issued $600 million of 3.15% senior notes due December 1, 2022 and $400 million of 4.625% senior notes due December 1, 2042. The increase in interest expense associated with these senior note issuances was partially offset by the repayment of $36 million of junior subordinated debt in March 2012 that carried a higher interest rate than our senior notes.

Income Taxes

Our effective tax rate during the 2013 quarter was 35.2% compared to the effective tax rate of 36.5% in the 2012 quarter primarily due to a change in our estimated tax liability associated with limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Insurance Reform Law.

Retail Segment

Membership: Medical membership: March 31, 2013 2012 Change Members Percentage
Individual Medicare Advantage 2,012,100 1,883,800 128,300 6.8%
Medicare stand-alone PDP 3,202,300 2,940,600 261,700 8.9%
Total Retail Medicare 5,214,400 4,824,400 390,000 8.1%
Individual commercial 548,400 509,300 39,100 7.7%
State-based Medicaid 73,300 46,100 27,200 59.0%
Total Retail medical members 5,836,100 5,379,800 456,300 8.5%
Individual specialty membership (a) 959,600 847,900 111,700 13.2%

(a) Specialty products include dental, vision, and other supplemental health and financial protection products. Members included in these products may not be unique to each product since members have the ability to enroll in multiple products.

(in millions)

Premiums and Services Revenue: Premiums: For the three months ended March 31, 2013 2012 Change Dollars Percentage
Individual Medicare Advantage $5,736 $5,093 $643 12.6%
Medicare stand-alone PDP 761 726 35 4.8%
Total Retail Medicare 6,497 5,819 678 11.7%
Individual commercial 279 244 35 14.3%
State-based Medicaid 79 46 33 71.7%
Individual specialty 49 38 11 28.9%
Total premiums 6,904 6,147 757 12.3%
Services 2 6 (4) (66.7)%
Total premiums and services revenue $6,906 $6,153 $753 12.2%
Income before income taxes $350 $128 $222 173.4%
Benefit ratio 85.9% 87.5% (1.6)%
Operating cost ratio 8.9% 10.4% (1.5)%

33

Pretax Results

  • Retail segment pretax income was $350 million in the 2013 quarter, an increase of $222 million, or 173.4%, compared to $128 million in the 2012 quarter primarily driven by membership and premium growth as well as a 160 basis point decrease in the benefit ratio together with a 150 basis point decrease in the operating cost ratio, both described below.

Enrollment

  • Individual Medicare Advantage membership increased 128,300 members, or 6.8%, from March 31, 2012 to March 31, 2013 reflecting net membership additions for the 2013 enrollment season. Effective January 1, 2013, we divested approximately 12,600 members acquired with Arcadian Management Services, Inc. in accordance with our previously disclosed agreement with the United States Department of Justice.
  • Medicare stand-alone PDP membership increased 261,700 members, or 8.9%, from March 31, 2012 to March 31, 2013 reflecting net membership additions, primarily for our Humana-Walmart plan offering, for the 2013 enrollment season.
  • Individual commercial medical membership increased 39,100 members, or 7.7%, from March 31, 2012 to March 31, 2013.
  • State-based Medicaid membership increased 27,200 members, or 59.0%, from March 31, 2012 to March 31, 2013, primarily driven by the addition of our recently awarded Kentucky Medicaid contract effective January 1, 2013 as discussed previously.
  • Individual specialty membership increased 111,700 members, or 13.2%, from March 31, 2012 to March 31, 2013 primarily driven by increased membership in dental and vision offerings.

Premiums

  • Retail segment premiums increased $757 million, or 12.3%, from the 2012 quarter to the 2013 quarter primarily due to a 9.4% increase in average individual Medicare Advantage membership. Individual Medicare Advantage per member premiums increased approximately 2.9% in the 2013 quarter compared to the 2012 quarter, including the impact of membership acquired with Arcadian on March 31, 2012.

Benefits expense

  • The Retail segment benefit ratio decreased 160 basis points from 87.5% in the 2012 quarter to 85.9% in the 2013 quarter primarily due to a decline in the benefit ratios associated with our individual Medicare Advantage and Medicare stand-alone PDP products primarily driven by higher favorable prior-period medical claims reserve development in the 2013 quarter than in the 2012 quarter, and favorable weekday seasonality, including the impact of an extra day’s claims from leap year in the 2012 quarter. The Retail segment’s pretax income for the 2013 quarter included the beneficial effect of $193 million in favorable prior-period medical claims reserve development versus $116 million in the 2012 quarter primarily driven by a lower claims trend year-over-year. This favorable prior-period medical claims reserve development decreased the Retail segment benefit ratio by approximately 280 basis points in the 2013 quarter versus approximately 190 basis points in the 2012 quarter.

Operating costs

  • The Retail segment operating cost ratio of 8.9% for the 2013 quarter decreased 150 basis points from 10.4% for the 2012 quarter reflecting scale efficiencies associated with servicing higher year-over-year membership together with our continued focus on operating cost efficiencies.

Employer Group Segment

Membership: Medical membership: March 31, 2013 2012 Change Members Percentage
Fully-insured commercial group 1,197,800 1,182,800 15,000 1.3%
ASO 1,200,800 1,236,600 (35,800) (2.9)%
Group Medicare Advantage 412,800 357,700 55,100 15.4%
Medicare Advantage ASO 0 28,100 (28,100) (100.0)%
Total group Medicare Advantage 412,800 385,800 27,000 7.0%
Group Medicare stand-alone PDP 3,800 4,200 (400) (9.5)%
Total group Medicare 416,600 390,000 26,600 6.8%
Total group medical members 2,815,200 2,809,400 5,800 0.2%
Group specialty membership (a) 7,274,000 6,849,300 424,700 6.2%

(a) Specialty products include dental, vision, and other supplemental health and financial protection products. Members included in these products may not be unique to each product since members have the ability to enroll in multiple products.

(in millions)

Premiums and Services Revenue: Premiums: For the three months ended March 31, 2013 2012 Change Dollars Percentage
Fully-insured commercial group $1,268 $1,242 $26 2.1%
Group Medicare Advantage 1,190 1,025 165 16.1%
Group Medicare stand-alone PDP 2 2 0 0.0%
Total group Medicare 1,192 1,027 165 16.1%
Group specialty 275 260 15 5.8%
Total premiums 2,735 2,529 206 8.1%
Services 88 91 (3) (3.3)%
Total premiums and services revenue $2,823 $2,620 $203 7.7%
Income before income taxes $205 $129 $76 58.9%
Benefit ratio 79.6% 81.2% (1.6)%
Operating cost ratio 15.5% 16.6% (1.1)%

35

Pretax Results

  • Employer Group segment pretax income increased $76 million, or 58.9%, to $205 million in the 2013 quarter primarily due to a 160 basis point decrease in the benefit ratio together with a 110 basis point improvement in the operating cost ratio as described below.

Enrollment

  • Fully-insured commercial group medical membership remained relatively unchanged, increasing 15,000 members, or 1.3%, from March 31, 2012 to March 31, 2013 as an increase in small group business membership was generally offset by lower membership in large group accounts.
  • Fully-insured group Medicare Advantage membership increased 55,100 members, or 15.4%, from March 31, 2012 to March 31, 2013 primarily due to the January 2013 addition of a new large group retirement account.
  • Effective January 1, 2013 we lost our sole group Medicare Advantage ASO account which had 28,100 members at March 31, 2012.
  • Group ASO commercial medical membership decreased 35,800 members, or 2.9%, from March 31, 2012 to March 31, 2013 primarily due to continued pricing discipline in a highly competitive environment for self-funded accounts.
  • Group specialty membership increased 424,700 members, or 6.2%, from March 31, 2012 to March 31, 2013 primarily due to increased cross-selling of our specialty products to our medical membership and growth in stand-alone specialty product sales.

Premiums

  • Employer Group segment premiums increased $206 million, or 8.1%, to $2.7 billion for the 2013 quarter primarily due to higher average group Medicare Advantage and fully-insured commercial group medical membership.

Benefits expense

  • The Employer Group segment benefit ratio decreased 160 basis points from 81.2% in the 2012 quarter to 79.6% in the 2013 quarter primarily due to higher favorable prior-period medical claims reserve development in the 2013 quarter than in the 2012 quarter and favorable weekday seasonality, including the impact of an extra day’s claims from leap year in the 2012 quarter. The Employer Group segment’s pretax income for the 2013 quarter included the beneficial effect of $76 million in favorable prior-period medical claims reserve development versus $15 million in the 2012 quarter primarily driven by a lower claims trend year-over-year. This favorable prior-period medical claims reserve development decreased the Employer Group segment benefit ratio by approximately 280 basis points in the 2013 quarter versus approximately 60 basis points in the 2012 quarter.

Operating costs

  • The Employer Group segment operating cost ratio of 15.5% for the 2013 quarter decreased 110 basis points from 16.6% for the 2012 quarter primarily reflecting growth in our group Medicare Advantage products which generally carry a lower operating cost ratio than our fully-insured commercial group products and continued savings as a result of our operating cost reduction initiatives.

Healthcare Services Segment

(in millions)

Revenues: Services: For the three months ended March 31, 2013 2012 Change Dollars Percentage
Provider services $282 $231 $51 22.1%
Home care services 23 0 23 100.0%
Pharmacy solutions 9 4 5 125.0%
Integrated behavioral health services 1 0 1 100.0%
Total services revenues 315 235 80 34.0%
Intersegment revenues:
Pharmacy solutions 3,085 2,929 156 5.3%
Provider services 227 50 177 354.0%
Home care services 60 36 24 66.7%
Integrated behavioral health services 31 34 (3) (8.8)%
Total intersegment revenues 3,403 3,049 354 11.6%
Total services and intersegment revenues $3,718 $3,284 $434 13.2%
Income before income taxes $125 $125 $0 0.0%
Operating cost ratio 95.7% 95.6% 0.1%

Pretax results

  • Healthcare Services segment pretax income of $125 million for the 2013 quarter was comparable to that of the 2012 quarter as revenue growth and the pretax income contribution from the acquisition of Metropolitan were generally offset by costs incurred in expanding our integrated care delivery model.

Script Volume

  • Script volumes for the Retail and Employer Group segment membership increased to approximately 67 million in the 2013 quarter, up 14% versus scripts of approximately 58 million in the 2012 quarter. The year-over-year increase primarily reflects growth associated with higher average medical membership for the 2013 quarter than in the 2012 quarter.

Services revenue

  • Provider services revenue increased $51 million, or 22.1%, from the 2012 quarter to $282 million for the 2013 quarter primarily due to the acquisitions of Metropolitan and SeniorBridge.

Intersegment revenues

  • Intersegment revenues increased $354 million, or 11.6%, from the 2012 quarter to $3.4 billion for the 2013 quarter primarily due to the acquisitions of Metropolitan in the fourth quarter of 2012 and SeniorBridge in the third quarter of 2012, as well as growth in our pharmacy solutions business as it serves our growing membership, particularly Medicare stand-alone PDP.

Operating costs

  • The Healthcare Services segment operating cost ratio of 95.7% for the 2013 quarter increased 10 basis points from 95.6% for the 2012 quarter.

Other Businesses

Pretax income for our Other Businesses of $58 million for the 2013 quarter increased $53 million compared to $5 million for the 2012 quarter primarily due to a reduction in benefits expense in the 2013 quarter related to a favorable settlement of contract claims with the DoD primarily associated with previously disclosed litigation settled in the second quarter of 2012.

Liquidity

Our primary sources of cash include receipts of premiums, services revenues, and investment and other income, as well as proceeds from the sale or maturity of our investment securities and borrowings. Our primary uses of cash include disbursements for claims payments, operating costs, interest on borrowings, taxes, purchases of investment securities, acquisitions, capital expenditures, repayments on borrowings, dividends, and share repurchases. Because premiums generally are collected in advance of claim payments by a period of up to several months, our business normally should produce positive cash flows during periods of increasing premiums and enrollment. Conversely, cash flows would be negatively impacted during periods of decreasing premiums and enrollment. From period to period, our cash flows may also be affected by the timing of working capital items. The use of operating cash flows may be limited by regulatory requirements which require, among other items, that our regulated subsidiaries maintain minimum levels of capital and seek approval before paying dividends from the subsidiaries to the parent.

For additional information on our liquidity risk, please refer to the section entitled “Risk Factors” in our 2012 Form 10-K.

Cash and cash equivalents increased to $1.4 billion at March 31, 2013 from $1.3 billion at December 31, 2012. The change in cash and cash equivalents for the three months ended March 31, 2013 and 2012 is summarized as follows:

(in millions)

2013 2012
Net cash provided by operating activities $412 $2,346
Net cash used in investing activities (392) (190)
Net cash provided by financing activities 72 123
Increase in cash and cash equivalents $92 $2,279

Cash Flow from Operating Activities

Our operating cash flows for the 2012 quarter were significantly impacted by the early receipt of the Medicare premium remittance for April 2012 of $2.0 billion in March 2012 because the payment date of April 1, 2012 fell on a weekend. Generally, when the first day of a month falls on a weekend or holiday, with the exception of January 1 (New Year’s Day), we receive this payment at the end of the previous month. Therefore, the 2012 quarter included four monthly Medicare payments compared to only three monthly Medicare payments during the 2013 quarter. This also resulted in an increase to unearned revenues in our condensed consolidated balance sheet at March 31, 2012.

Excluding the impact from the timing of the Medicare premium receipt, the increase in operating cash flows from the 2012 quarter to the 2013 quarter primarily results from higher earnings and the timing of working capital items, including favorable weekday seasonality, which includes the impact of an extra day’s claims for leap year in the 2012 quarter.

Comparisons of our operating cash flows also are impacted by other changes in our working capital. The most significant drivers of changes in our working capital are typically the timing of payments of benefits expense and receipts for premiums. We illustrate these changes with the following summaries of benefits payable and receivables.

The detail of benefits payable was as follows at March 31, 2013 and December 31, 2012:

(in millions)

March 31, 2013 December 31, 2012 2013 Quarter Change 2012 Quarter Change
IBNR (1) $2,696 $2,552 $144 $235
Reported claims in process (2) 493 315 178 85
Other benefits payable (3) 901 912 (11) 34
Total benefits payable $4,090 $3,779 311 354
Reconciliation to cash flow statement:
Payables from acquisition 0 (70)
Change in benefits payable per cash flow statement resulting in cash from operations $311 $284

(1) IBNR represents an estimate of benefits payable for claims incurred but not reported (IBNR) at the balance sheet date. The level of IBNR is primarily impacted by membership levels, medical claim trends and the receipt cycle time, which represents the length of time between when a claim is initially incurred and when the claim form is received (i.e. a shorter time span results in a lower IBNR).

(2) Reported claims in process represents the estimated valuation of processed claims that are in the post claim adjudication process, which consists of administrative functions such as audit and check batching and handling, as well as amounts owed to our pharmacy benefit administrator which fluctuate due to bi-weekly payments and the month-end cutoff.

(3) Other benefits payable include amounts owed to providers under capitated and risk sharing arrangements.

The increase in benefits payable from December 31, 2012 to March 31, 2013 primarily was due to an increase in IBNR, primarily as a result of Medicare Advantage membership growth, and an increase in the amount of processed but unpaid claims, including amounts due to our pharmacy benefit administrator which fluctuate due to month-end cutoff. The increase in benefits payable from December 31, 2011 to March 31, 2012 primarily was due to the same factors resulting in the increase in benefits payable from December 31, 2012 to March 31, 2013 described above.

The detail of total net receivables was as follows at March 31, 2013 and December 31, 2012:

(in millions)

March 31, 2013 December 31, 2012 2013 Quarter Change 2012 Quarter Change
Medicare $809 $422 $387 $223
Commercial and other 461 346 115 60
Military services 156 59 97 17
Allowance for doubtful accounts (105) (94) (11) (4)
Total net receivables $1,321 $733 588 296
Reconciliation to cash flow statement:
Receivables from acquisition 0 (41)
Change in receivables per cash flow statement resulting in cash from operations $588 $255

Medicare receivables are impacted by the timing of accruals and related collections associated with the CMS risk-adjustment model. The increase in Medicare receivables at March 31, 2013 reflects an increase in Medicare risk-adjustment revenue receivable.

Military services receivables at March 31, 2013 and December 31, 2012 consist of administrative services only fees owed from the federal government for administrative services provided under our new TRICARE South Region contract and final settlement balances due under our previous TRICARE South Region contract that expired on March 31, 2012. The March 31, 2013 receivable also includes $48 million related to a favorable settlement of contract claims with the DoD previously discussed. As disclosed previously, we account for our new TRICARE South Region contract similar to an administrative services fee only agreement. As such, beginning April 1, 2012, payments of the federal government’s claims and related reimbursements for the new TRICARE South Region contract are classified with receipts (withdrawals) from contract deposits as a financing item in our consolidated statements of cash flows.

Commercial and other receivables reflect the timing of reimbursements from the Puerto Rico Health Insurance Administration for our Medicaid business.

In addition to the timing of receipts for premiums and services revenues and payments of benefits expense, other working capital items impacting operating cash flows primarily resulted from the timing of payments for the Medicare Part D risk corridor provisions of our contracts with CMS and changes in the timing of the collection of pharmacy rebates.

Cash Flow from Investing Activities

We reinvested a portion of our operating cash flows in investment securities, primarily investment-grade fixed income securities, totaling $297 million in the 2013 quarter and $48 million in the 2012 quarter.

Our ongoing capital expenditures primarily relate to our information technology initiatives, support of services in our provider services operations including medical and administrative facility improvements necessary for activities such as the provision of care to members, claims processing, billing and collections, wellness solutions, care coordination, regulatory compliance and customer service. Total capital expenditures, excluding acquisitions, were $90 million in the 2013 quarter and $86 million in the 2012 quarter reflecting increased spending associated with growth in our provider services and pharmacy businesses in our Healthcare Services segment. Excluding acquisitions, we expect total capital expenditures in 2013 in a range of approximately $425 million to $450 million.

Cash consideration paid for acquisitions, net of cash acquired, of $56 million in the 2012 quarter primarily relates to the acquisition of Arcadian.

Cash Flow from Financing Activities

Receipts from CMS associated with Medicare Part D claim subsidies for which we do not assume risk were $249 million higher than claims payments during the 2013 quarter and $298 million higher than claims payments during the 2012 quarter. Under our new administrative services only TRICARE South Region contract that began April 1, 2012, health care cost payments for which we do not assume risk exceeded reimbursements from the federal government by $13 million during the 2013 quarter.

We repurchased 1.21 million shares of our common stock for $81 million in the 2013 quarter and 1.15 million shares of our common stock for $100 million in the 2012 quarter under share repurchase plans authorized by the Board of Directors. We also acquired shares of our common stock in connection with employee stock plans for an aggregate cost of $13 million in the 2013 quarter and $51 million in the 2012 quarter.

During the 2013 quarter, we paid dividends to stockholders of $42 million compared to $41 million in the 2012 quarter as discussed further below.

In March 2012, we repaid, without penalty, junior subordinated long-term debt of $36 million.

Future Sources and Uses of Liquidity

Dividends

Our Board of Directors approved a quarterly cash dividend policy. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.

The following table provides details of dividend payments in 2012 and 2013:

(in millions)

Record Date 2012 payments Payment Date Amount per Share Total Amount
12/30/2011 1/31/2012 $0.25 $41
3/30/2012 4/27/2012 $0.25 $41
6/29/2012 7/27/2012 $0.26 $42
9/28/2012 10/26/2012 $0.26 $41
2013 payments
12/31/2012 1/25/2013 $0.26 $42
3/28/2013 4/26/2013 $0.26 $41

In April 2013, the Board of Directors declared a cash dividend of $0.27 per share payable on July 26, 2013 to stockholders of record on June 28, 2013.

Stock Repurchases

In April 2013, the Board of Directors replaced its previously approved share repurchase authorization of up to $1 billion (of which $557 million remained unused) with the current authorization for repurchases of up to $1 billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring on June 30, 2015. Under the current share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, or in privately-negotiated transactions, subject to certain regulatory restrictions on volume, pricing, and timing. During the 2012 quarter, we repurchased 1.15 million shares in open market transactions for $100 million at an average price of $86.95 under a previously approved share repurchase authorization. During the 2013 quarter, we repurchased 1.21 million shares in open market transactions for $81 million at an average price of $67.60 under a previously approved share repurchase authorization. As of May 1, 2013, the remaining authorized amount under the current authorization totaled $1 billion.

In connection with employee stock plans, we acquired 0.2 million common shares for $13 million and 0.6 million common shares for $51 million during the three months ended March 31, 2013 and 2012, respectively.

Senior Notes

In December 2012, we issued $600 million of 3.15% senior notes due December 1, 2022 and $400 million of 4.625% senior notes due December 1, 2042. Our net proceeds, reduced for the discount and cost of the offering, were $990 million. We used the proceeds from the offering primarily to finance the acquisition of Metropolitan, including the retirement of Metropolitan’s indebtedness, and to pay related fees and expenses. We previously issued $500 million of 6.45% senior notes due June 1, 2016, $500 million of 7.20% senior notes due June 15, 2018, $300 million of 6.30% senior notes due August 1, 2018, and $250 million of 8.15% senior notes due June 15, 2038. The 7.20% and 8.15% senior notes are subject to an interest rate adjustment if the debt ratings assigned to the notes are downgraded (or subsequently upgraded). In addition, our 7.20%, 8.15%, 3.15%, and 4.625% senior notes contain a change of control provision that may require us to purchase the notes under certain circumstances. All six series of our senior notes, which are unsecured, may be redeemed at our option at any time at 100% of the principal amount plus accrued interest and a specified make-whole amount.

Credit Agreement

Our 5-year $1.0 billion unsecured revolving agreement expires in November 2016. Under the credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The LIBOR spread, currently 120 basis points, varies depending on our credit ratings ranging from 87.5 to 147.5 basis points. We also pay an annual facility fee regardless of utilization. This facility fee, currently 17.5 basis points, may fluctuate between 12.5 and 27.5 basis points, depending upon our credit ratings. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option.

The terms of the credit agreement include standard provisions related to conditions of borrowing, including a customary material adverse effect clause which could limit our ability to borrow additional funds. In addition, the credit agreement contains customary restrictive and financial covenants as well as customary events of default, including financial covenants regarding the maintenance of a minimum level of net worth of $6.8 billion at March 31, 2013 and a maximum leverage ratio of 3.0:1. We are in compliance with the financial covenants, with actual net worth of $9.2 billion and an actual leverage ratio of 0.9:1, as measured in accordance with the credit agreement as of March 31, 2013. In addition, the credit agreement includes an uncommitted $250 million incremental loan facility.

At March 31, 2013, we had no borrowings outstanding under the credit agreement. We have outstanding letters of credit of $5 million secured under the credit agreement. No amounts have been drawn on these letters of credit. Accordingly, as of March 31, 2013, we had $995 million of remaining borrowing capacity under the credit agreement, none of which would be restricted by our financial covenant compliance requirement. We have other customary, arms-length relationships, including financial advisory and banking, with some parties to the credit agreement.

Other Long-Term Borrowings

In March 2012, we repaid, without penalty, junior subordinated debt of $36 million. Prior to repayment, the junior subordinated debt bore a fixed annual interest rate of 8.02% payable quarterly until 2012, and then payable at a floating rate based on LIBOR plus 310 basis points.

Liquidity Requirements

We believe our cash balances, investment securities, operating cash flows, and funds available under our credit agreement or from other public or private financing sources, taken together, provide adequate resources to fund ongoing operating and regulatory requirements, acquisitions, future expansion opportunities, and capital expenditures for at least the next twelve months, as well as to refinance or repay debt, and repurchase shares.

Adverse changes in our credit rating may increase the rate of interest we pay and may impact the amount of credit available to us in the future. Our investment-grade credit rating at March 31, 2013 was BBB according to Standard & Poor’s Rating Services, or S&P, and Baa3 according to Moody’s Investors Services, Inc., or Moody’s. A downgrade by S&P to BB+ or by Moody’s to Ba1 triggers an interest rate increase of 25 basis points with respect to $750 million of our senior notes. Successive one notch downgrades increase the interest rate an additional 25 basis points, or annual interest expense by $2 million, up to a maximum 100 basis points, or annual interest expense by $8 million.

In addition, we operate as a holding company in a highly regulated industry. Humana Inc., our parent company, is dependent upon dividends and administrative expense reimbursements from our subsidiaries, most of which are subject to regulatory restrictions. We continue to maintain significant levels of aggregate excess statutory capital and surplus in our state-regulated operating subsidiaries. Cash, cash equivalents, and short-term investments at the parent company were $202 million at March 31, 2013 compared to $346 million at December 31, 2012. As described above in the section titled “Health Insurance Reform,” the NAIC is continuing discussions regarding the accounting for the health insurance industry fee required by the Health Insurance Reform Law and may require accrual and associated subsidiary funding consideration for the first two years of the assessment in 2014 followed by annual accruals thereafter. The NAIC guidance is contradictory to final GAAP guidance issued by the FASB in July 2011, which requires annual accrual of the health insurance industry fee in the year in which it is payable.

Regulatory Requirements

Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity’s level of statutory income and statutory capital and surplus. In most states, prior notification is provided before paying a dividend even if approval is not required. Actual dividends paid may vary due to consideration of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix.

Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Based on the most recently filed statutory financial statements as of December 31, 2012, our state regulated subsidiaries had aggregate statutory capital and surplus of approximately $5.1 billion, which exceeded aggregate minimum regulatory requirements. The amount of dividends that we expect to be paid to our parent company in 2013 is approximately $970 million in the aggregate, subject to state regulatory approval. This compares to dividends that were paid in 2012 of approximately $1.2 billion. The year-over-year decline primarily is a result of higher surplus requirements associated with premium growth.

Market risk

As filed, 2,117 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.

Interest rate risk also represents a market risk factor affecting our consolidated financial position due to our significant investment portfolio, consisting primarily of fixed maturity securities of investment-grade quality with a weighted average S&P credit rating of AA- at March 31, 2013. Our net unrealized position declined $53 million from a net unrealized gain position of $728 million at December 31, 2012 to a net unrealized gain position of $675 million at March 31, 2013. At March 31, 2013, we had gross unrealized losses of $13 million on our investment portfolio primarily due to an increase in market interest rates and tighter liquidity conditions in the current markets than when the securities were purchased, and as such, there were no material other-than-temporary impairments during the three months ended March 31, 2013. While we believe that these impairments are temporary and we currently do not have the intent to sell such securities, given the current market conditions and the significant judgments involved, there is a continuing risk that future declines in fair value may occur and material realized losses from sales or other-than-temporary impairments may be recorded in future periods.

Duration is the time-weighted average of the present value of the bond portfolio’s cash flow. Duration is indicative of the relationship between changes in fair value and changes in interest rates, providing a general indication of the sensitivity of the fair values of our fixed maturity securities to changes in interest rates. However, actual fair values may differ significantly from estimates based on duration. The average duration of our investment portfolio, including cash and cash equivalents, was approximately 4.2 years as of March 31, 2013 and 4.0 years as of December 31, 2012. Based on the duration including cash equivalents, a 1% increase in interest rates would generally decrease the fair value of our securities by approximately $465 million.

Controls and procedures

As filed, 1,276 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our Chief Executive Officer, or CEO, our Chief Financial Officer, or CFO, and our Principal Accounting Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures for the quarter ended March 31, 2013.

Based on our evaluation, our CEO, CFO, and Principal Accounting Officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information the Company is required to disclose in its reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including, without limitation, ensuring that such information is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There have been no changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 168 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no changes to the risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the SEC on February 21, 2013.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-01-01 to 2013-03-31$10.49bnus-gaap:Revenues
Selling, general and administrative3 months2013-01-01 to 2013-03-31$1.45bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2013-01-01 to 2013-03-31$765.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-01-01 to 2013-03-31$35.0mus-gaap:InterestExpense
Income tax3 months2013-01-01 to 2013-03-31$257.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-01-01 to 2013-03-31$473.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-01-01 to 2013-03-31$2.95us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-01-01 to 2013-03-31$2.97us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-01-01 to 2013-03-31160,403,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-01-01 to 2013-03-31$412.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2013-01-01 to 2013-03-31$90.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2013-01-01 to 2013-03-31$42.0mus-gaap:PaymentsOfDividends
Share repurchases3 months2013-01-01 to 2013-03-31$94.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-03-31$1.40bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$12.68bnus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$20.97bnus-gaap:Assets
Current liabilitiesAt period end2013-03-31$6.94bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-03-31$11.81bnus-gaap:Liabilities
Long-term debtAt period end2013-03-31$2.61bnus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2013-03-31$9.16bnus-gaap:StockholdersEquity
Shares outstandingAt period end2013-03-31157,501,751 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-13-192313. Last ingested by Listed: Nov 13, 2026, 14:11 ET. Listed shows no prices and gives no investment advice.